tiprankstipranks

Douglas A Treco Insider Profile

4 Followers
Douglas A Treco, President & CEO, Director at Ra Pharmaceuticals, holds 0.00 shares in Ra Pharmaceuticals (Ticker: RARX), holds ― shares in Crispr Therapeutics AG (Ticker: CRSP), holds 20.66K shares in Inozyme Pharma (Ticker: INZY).
tipranks
Douglas A Treco

Douglas A Treco
Ra Pharmaceuticals (RARX)
President & CEO, Director

Not Ranked
Douglas A Treco has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$92K
100.00%
0.00%
A breakdown of Douglas A Treco's holdings

Insider Roles

Inozyme Pharma
(INZY)
CEO, Director
Crispr Therapeutics AG
(CRSP)
Director
Roles that Douglas A Treco holds in companies

Most Profitable Insider Trade

Stock:
Inozyme Pharma
(INZY)
Rating:Informative Sell
Date:Apr 03, 2024 - Today
Return:+38.00%
The most profitable trade made by Douglas A Treco

Douglas A Treco's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RARX
Ra Pharmaceuticals
Apr 03, 2020
Uninformative Sell
11.27M
$0.00
Crispr Therapeutics AG
Director
Inozyme Pharma
Apr 03, 2024
CEO, Director
Uninformative Buy
$91.75K
List of latest transactions for each holding click on a transaction to see Douglas A Treco's performance on stock

Douglas A Treco insider profile FAQ

What is the percentage of profitable transactions made by Douglas A Treco?
The percentage of profitable transactions made by Douglas A Treco is ―.
    What is the average return per transaction made by Douglas A Treco?
    The average return per transaction made by Douglas A Treco is ―.
      What stocks does Douglas A Treco hold?
      Douglas A Treco holds: RARX, CRSP, INZY stocks.
        What was Douglas A Treco’s latest transaction?
        Douglas A Treco latest transaction was an Uninformative Sell of $11.27M.
          What was Douglas A Treco's most profitable transaction?
          Douglas A Treco’s most profitable transaction was an Informative Sell of INZY stock on April 3, 2024. The return on the trade was 38.00%.
            What is Douglas A Treco's role in Ra Pharmaceuticals?
            Douglas A Treco's role in Ra Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.